Barrington lowered the firm’s price target on Option Care Health (OPCH) to $32 from $40 and keeps an Outperform rating on the shares following the Q3 report. The firm cites the company’s commentary related to the Stelara issue for the target cut.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH: